TNF-α is a pivotal mediator of inflammation, and the monoclonal antibody infliximab, which targets TNF-α, is widely used to treat inflammatory diseases such as Crohn’s disease and ulcerative colitis [45]. This evidence concerns the gene TNF and Crohn disease.